aTyr Pharma shareholders approve 5M share increase to equity plan; elect two directors

aTYR PHARMA INC

Stockholders approved amendment to 2015 Stock Plan, increasing share reserve by 5,000,000 to 15,719,300 shares.
Incentive stock option term extended to February 26, 2035.
Class I directors Paul Schimmel and Sara L. Zaknoen elected with 56.6M and 49.0M votes for, respectively.
Ratification of Ernst & Young as auditor for FY2025 approved (68.9M for, 175K against).
Advisory vote on named executive officer compensation approved (55.2M for, 1.35M against).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.